scholarly article | Q13442814 |
P2093 | author name string | Hassan Ahmadnia | |
Kazem Anvari | |||
Abdolazim Sedighi Pashaki | |||
Mahdi Karimi Shahri | |||
Mehdi Seilanian Toussi | |||
Mehrdad Katebi | |||
Mahdieh Dayani | |||
Shahram Naseri | |||
Mahmoud Kalantari | |||
Maryam Broumand | |||
P433 | issue | 1 | |
P921 | main subject | metastatic prostate carcinoma | Q55779807 |
P304 | page(s) | 381-388 | |
P577 | publication date | 2012-01-01 | |
P1433 | published in | Urology journal | Q26841898 |
P1476 | title | Expression of Bcl-2 and Bax in advanced or metastatic prostate carcinoma | |
P478 | volume | 9 |
Q33708677 | BCL2 genotypes and prostate cancer survival |
Q41463153 | BH3 Mimetics for the Treatment of Prostate Cancer |
Q47547132 | FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-XL cell survival genes |
Q35023204 | Lack of association between Bax promoter (-248G>A) single nucleotide polymorphism and susceptibility towards cancer: evidence from a meta-analysis |
Q90048237 | Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer |
Q42184292 | Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues |
Q36360770 | Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy |
Q41970044 | The acute lymphoblastic leukemia prognostic scoring whether it is possible by BCL-2, BAX gene promoter genotyping |
Q34502603 | Therapeutic mechanism of treating SMMC-7721 liver cancer cells with magnetic fluid hyperthermia using Fe₂O₃ nanoparticles |
Q91942429 | Tumor-Specific Induction of the Intrinsic Apoptotic Pathway-A New Therapeutic Option for Advanced Prostate Cancer? |
Search more.